SCHEMBL30069342

SCHEMBL30069342

CCOC(=O)C1CC(F)CN(C(=O)OCc2ccccc2)C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.49
NPC1 O15118 3/20 0.49
RAB9A P51151 2/20 0.49
ALDH1A1 P00352 3/20 0.48
CYP2C19 P33261 2/20 0.47
HPGD P15428 1/20 0.47
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
MAPT P10636 1/20 0.44
NPSR1 Q6W5P4 2/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
HTT P42858 1/20 0.44
PKM P14618 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
GABRA1 P14867 2/20 0.43
GABRG2 P18507 2/20 0.43
GABRB3 P28472 2/20 0.43
GABRA3 P34903 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12501575 0.89 SMN1; SMN2 (0.52) SMN1; SMN2NPC1RAB9AALDH1A1CYP2C19
SCHEMBL1441322 0.89 SMN1; SMN2 (0.52) SMN1; SMN2NPC1RAB9AALDH1A1CYP2C19
SCHEMBL30453534 0.89 SMN1; SMN2 (0.52) SMN1; SMN2NPC1RAB9AALDH1A1CYP2C19
SCHEMBL28390258 0.89 ALDH1A1 (0.58) SMN1; SMN2NPC1RAB9AALDH1A1CYP2C19
SCHEMBL14636622 0.87 SMN1; SMN2 (0.50) SMN1; SMN2NPC1RAB9AALDH1A1CYP2C19
SCHEMBL29068072 0.87 SMN1; SMN2 (0.61) SMN1; SMN2NPC1RAB9AALDH1A1CYP2C19
SCHEMBL10189884 0.87 SMN1; SMN2 (0.61) SMN1; SMN2NPC1RAB9AALDH1A1CYP2C19
SCHEMBL1441152 0.87 SMN1; SMN2 (0.61) SMN1; SMN2NPC1RAB9AALDH1A1CYP2C19
SCHEMBL29067884 0.85 SMN1; SMN2 (0.53) SMN1; SMN2NPC1RAB9AALDH1A1CYP2C19
SCHEMBL29067886 0.85 SMN1; SMN2 (0.53) SMN1; SMN2NPC1RAB9AALDH1A1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022237649-A1 EXOCYCLIC AMINO QUINAZOLINE DERIVATIVES AS KRAS INHIBITORS NIKANG THERAPEUTICS, INC. (US) 2022-11-17 WO disclosed